As a tumor suppressor, tRF3E competes with the over-expressed RNA binding protein nucleolin (NCL) in BC to cause the release of p53 mRNA, which in turn promotes the translation of p53, thereby inhibiting the proliferation of cancer cells95. Here, TP53 is linked to cancer.